Gilead Sciences, Inc. (GILD)
144.22
-0.92
(-0.63%)
USD |
NASDAQ |
Mar 06, 10:18
Gilead Sciences Market Cap : 179.04B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 198.89B |
| Johnson & Johnson | 569.89B |
| Regeneron Pharmaceuticals, Inc. | 80.14B |
| Arcellx, Inc. | 6.707B |
| Moderna, Inc. | 20.45B |
Market Cap Related Metrics
| PE Ratio | 21.26 |
| PS Ratio | 6.147 |
| PEG Ratio | 0.0121 |
| Price to Book Value | 7.886 |
| Price to Free Cash Flow | 19.14 |
| Price | 144.22 |
| Earnings Yield | 4.70% |
| PEGY Ratio | 0.0121 |
| Operating PE Ratio | 15.31 |
| Normalized PE Ratio | 19.06 |